Five rapid-cycling manic patients developed neurotoxic syndromes when
treated with a combination of lithium and carbamazepine, although all five
had therapeutic plasma levels of both drugs. The risk factors for
development of neurotoxicity with this drug combination are discussed.
Abstract Teaser